Eisai
4523.T
#2250
Rank
HK$65.38 B
Marketcap
HK$231.78
Share price
-1.03%
Change (1 day)
11.41%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): HK$6.78

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$6.76. an increase over its 2024 EPS that were of HK$7.62.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025HK$8.5211.85%
2024HK$7.62-32.63%
2023HK$11.315.52%
2022HK$10.71-74.01%
2021HK$41.22-66.58%
2020HK$123.3298.24%
2019HK$62.2117.01%
2018HK$53.1637.78%
2017HK$38.59-27.62%
2016HK$53.3135.33%
2015HK$39.39-2.82%
2014HK$40.54-27.66%
2013HK$56.04-27.49%
2012HK$77.29-12.67%
2011HK$88.5188.08%
2010HK$47.06-11.06%
2009HK$52.91-390.15%
2008-HK$18.24-127.78%
2007HK$65.6611.78%
2006HK$58.744.38%
2005HK$56.287.4%
2004HK$52.4043.03%
2003HK$36.6425.09%
2002HK$29.2952.67%
2001HK$19.1869.76%
2000HK$11.30